A Study To Evaluate Benefit and Risk Between Two Different Dose Schedule Of Internal Radiation Treatment In Cancer Cervix Patients
- Conditions
- Health Condition 1: C531- Malignant neoplasm of exocervix
- Registration Number
- CTRI/2023/04/051952
- Lead Sponsor
- SVIMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Histopathologically confirmed carcinoma of Uterine cervix
Patients of age group 18 to 70 years.
Patients with performance status of 0 to 2
Stage II B- III C with intact cervix.
Patients with gross residual disease after EBRT not suitable for ICRT
Distorted Geometry like narrow vagina and os not soundable
Post hysterectomy Carcinoma vault
Post supra cervical hysterectomy with carcinoma of cervical stump.
Extensive para vaginal and distal vaginal involvement
Patients who has given approved informed consent
Post EBRT parametrial involvement of more than medial one third
Patients with distant metastasis
Patients with prior EBRT and Brachytherapy to pelvis
Patients with ECOG performance status of 3-4
Pregnant women and lactating mothers
Patients who has not given informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumour ResponseTimepoint: 6 months
- Secondary Outcome Measures
Name Time Method Proctitis and CystitisTimepoint: 6 months